Company Description
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.
The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine.
The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt.
The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors.
The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
| Country | China |
| Founded | 2004 |
| IPO Date | Jan 7, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 277 |
| CEO | Songlin Song |
Contact Details
Address: No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin, 132101 China | |
| Phone | 86 432 6304 7008 |
| Website | jlzybio.com |
Stock Details
| Ticker Symbol | ZYBT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| IPO Price | $4.00 |
| CIK Code | 0001975641 |
| ISIN Number | KYG989MS1016 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Aiden Han | Co-Chief Executive Officer |
| Songlin Song | Co-Chief Executive Officer |
| Ping Wang | Chief Financial Officer |
| Zhongyao Liu | Chief Operating Officer |
| Yuhong Cheng | Vice General Manager |
| Wei Lian | Vice General Manager |
| Yuyou He | Vice General Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 3, 2025 | 20-F | Annual and transition report of foreign private issuers |
| May 23, 2025 | 6-K | Report of foreign issuer |
| Apr 29, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 3, 2025 | 6-K | Report of foreign issuer |
| Mar 6, 2025 | 6-K | Report of foreign issuer |
| Feb 21, 2025 | SCHEDULE 13G | Filing |
| Jan 14, 2025 | 6-K | Report of foreign issuer |
| Jan 8, 2025 | 6-K | Report of foreign issuer |
| Jan 7, 2025 | 424B4 | Prospectus |
| Jan 6, 2025 | CERT | Certification by an exchange approving securities for listing |